EN-001

N/A

Report date: 2025/03/18 16:38:19

Base Information

Drug NameEN-001
Drug Alias NameAllogeneic umbilical cord-derived mesenchymal stem cellsEN-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Wharton's Jelly-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCharcot-Marie-Tooth DiseaseMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesENCell Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCell Resources CorpLucy Biotech LtdENCell Co Ltd
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth DiseaseMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A